Salem Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.92M Sell
17,074
-1,748
-9% -$709K 0.22% 76
2025
Q1
$9.37M Buy
18,822
+1,158
+7% +$576K 0.33% 53
2024
Q4
$9.19M Buy
17,664
+930
+6% +$484K 0.3% 51
2024
Q3
$10.4M Sell
16,734
-21
-0.1% -$13K 0.31% 52
2024
Q2
$9.27M Sell
16,755
-305
-2% -$169K 0.3% 53
2024
Q1
$9.92M Buy
17,060
+1,996
+13% +$1.16M 0.33% 52
2023
Q4
$8M Sell
15,064
-5,529
-27% -$2.94M 0.27% 56
2023
Q3
$10.4M Buy
20,593
+2,215
+12% +$1.12M 0.4% 46
2023
Q2
$9.6M Buy
18,378
+1,795
+11% +$937K 0.35% 49
2023
Q1
$9.56M Buy
16,583
+9,888
+148% +$5.7M 0.38% 46
2022
Q4
$3.69M Buy
6,695
+3,060
+84% +$1.69M 0.16% 91
2022
Q3
$1.85M Buy
3,635
+47
+1% +$23.9K 0.08% 131
2022
Q2
$1.95M Sell
3,588
-1
-0% -$543 0.09% 132
2022
Q1
$2.12M Sell
3,589
-531
-13% -$314K 0.08% 132
2021
Q4
$2.75M Buy
4,120
+177
+4% +$118K 0.1% 116
2021
Q3
$2.25M Buy
3,943
+872
+28% +$498K 0.12% 131
2021
Q2
$1.55M Buy
3,071
+318
+12% +$160K 0.09% 150
2021
Q1
$1.26M Buy
2,753
+126
+5% +$57.5K 0.08% 151
2020
Q4
$1.22M Buy
2,627
+247
+10% +$115K 0.08% 143
2020
Q3
$1.05M Buy
2,380
+1,354
+132% +$598K 0.08% 142
2020
Q2
$372K Buy
1,026
+36
+4% +$13.1K 0.03% 199
2020
Q1
$281K Buy
990
+73
+8% +$20.7K 0.03% 204
2019
Q4
$298K Buy
917
+17
+2% +$5.53K 0.02% 222
2019
Q3
$262K Buy
900
+390
+76% +$114K 0.02% 224
2019
Q2
$150K Hold
510
0.01% 267
2019
Q1
$124K Buy
+510
New +$124K 0.01% 226
2018
Q4
Sell
-510
Closed -$124K 370
2018
Q3
$124K Hold
510
0.01% 226
2018
Q2
$106K Buy
510
+200
+65% +$41.6K 0.01% 231
2018
Q1
$63K Hold
310
0.01% 266
2017
Q4
$59K Buy
310
+60
+24% +$11.4K 0.01% 296
2017
Q3
$48K Sell
250
-30
-11% -$5.76K 0.01% 310
2017
Q2
$49K Buy
280
+30
+12% +$5.25K 0.01% 318
2017
Q1
$39K Sell
250
-36
-13% -$5.62K ﹤0.01% 409
2016
Q4
$40K Buy
286
+36
+14% +$5.04K ﹤0.01% 379
2016
Q3
$398 Buy
+250
New +$398 0.01% 337